Summary
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
History
Pharmaron Beijing Co., Ltd. was founded in Beijing in 2001. Since then, it has grown from a small, regional CRO to the largest Chinese CRO with a global presence. Pharmaron has offices in Beijing, Shanghai, and San Francisco, as well as in the United States, Canada, UK, Europe, South Africa, Australia, and Japan.
Mission
At Pharmaron, we strive to provide the highest quality integrated research and development services for both small and large companies in the global pharmaceutical and biotechnology industries.
Vision
Our vision is to be the leading CRO in the world, providing value-added services to our clients and helping them develop innovative medicines and therapies to benefit society.
Key Team
Mr. Shing Chung Li C.F.A., C.P.A. (CFO & Sec. of the Board)
Dr. Hua Yang Ph.D. (Chief Scientific Officer & Deputy Mang.)
Mr. Henry Tang (VP of Legal Affairs)
Dr. Connie Sun (Sr. VP of Bus. & Corp. Devel.)
Ms. Celina Zhong (Sr. VP of HR)
Ms. Katherine Lee M.B.A., MBA (Chief Bus. Officer)
Ms. Jane Zhang Ph.D. (Chief Quality Officer of Discovery Services)
Recognition and Awards
Pharmaron Beijing has been recognized with numerous awards, including the China International Quality Award, the Asia Pacific Top Employer Award, and the China Asset Management Top Employer Award.
References
